FINANCIALS

REGN Regeneron Pharmaceuticals Inc 872589

Income Statement
Revenue	regn-20241231	14,202,000,000
Net Income	regn-20241231	4,412,600,000
Profit Margin		31.07%

Balance Sheet
Current Assets	18,660,900,000
Assets	37,759,400,000
Current Liabilities	3,944,300,000
Liabilities	8,405,800,000
Equity	29,353,600,000
Shares Out	108,417,000

Cash Flow Statement
Operating Cash Flow	4,420,500,000
Investing Cash Flow	-2,468,100,000

Market Analysis
Market Cap	125,407,729,905
Price	664.79
BVPS	270.75
PB	2.48
EPS	37.77
PE	30.12
PS	2.21
FCF	1,952,400,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view REGN documents filed with the SEC.

REGN Filings Clear

View A List of Tickers